原发性心脏淋巴瘤与HIV：一项全国范围的住院分析

Background: Primary Cardiac Lymphoma (PCL) is an exceptionally rare malignancy. While clinical case reports have postulated an association with human immunodeficiency virus (HIV), large-scale epidemiological data corroborating this link are limited. Objective: To determine whether HIV is associated with increased prevalence of PCL in a large, nationally representative sample of US hospitalizations. Methods: We performed a retrospective, cross-sectional analysis using the Healthcare Cost and Utilization Project National Inpatient Sample from 2016 to 2019, representing approximately 35 million unweighted hospitalizations. Hospitalizations were identified using a proxy definition for PCL, requiring ICD-10-CM codes for both cardiomyopathy (I42.*) and extranodal non-Hodgkin lymphoma (i.e., C83.39, C85.99). HIV status was identified using codes B20-B24 and Z21. We compared the prevalence of PCL in hospitalizations with versus without HIV and calculated odds ratios using Fisher's Exact Test, reporting corresponding 95% confidence intervals (CI) and p-values. Results: We identified 569 hospitalizations meeting our operational definition for PCL out of 34,955,252 total discharges. The prevalence of PCL was significantly higher among hospitalizations with HIV (6.2 per 100,000) compared with those without HIV (1.6 per 100,000; p < 0.0001). HIV was associated with a 3.86-fold increased odds of PCL (OR: 3.86; 95% CI: 2.23-6.70; p < 0.0001). Conclusion: In this nationwide analysis of 35 million hospitalizations, HIV was strongly associated with a higher prevalence of PCL. Hospitalizations with HIV had nearly 4-fold higher odds of PCL, as defined by co-occurrence of cardiomyopathy and extranodal lymphoma, compared with hospitalizations without HIV. This population-level finding evinces the association previously suggested in clinical case reports.